ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3792 | NERV Minerva Neurosciences, Inc - Common Stock | 2.36 USD | -2.48% | -25.79% | -33.71% | -2.07% | 112.68 M USD | ||
| 3797 | SEER Seer, Inc. - Class A Common Stock | 2.02 USD | -0.98% | -9.42% | +5.76% | -7.34% | 111.85 M USD | ||
| 3800 | FHTX Foghorn Therapeutics Inc. - Common Stock | 1.88 USD | -0.53% | -8.74% | -55.97% | -53.92% | 111.64 M USD | ||
| 3807 | APYX Apyx Medical Corporation - Common Stock | 2.60 USD | +1.56% | +4.84% | -14.47% | -15.03% | 109.52 M USD | ||
| 3808 | GNLX Genelux Corporation - Common Stock | 2.42 USD | -2.42% | -2.81% | +2.54% | -55.35% | 109.49 M USD | ||
| 3809 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.09 USD | -5.22% | -14.17% | -42.93% | +5.83% | 109.28 M USD | ||
| 3811 | VTVT vTv Therapeutics Inc. - Class A Common Stock | 26.74 USD | -3.08% | -12.73% | -13.43% | +30.44% | 105.73 M USD | ||
| 3814 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 6.27 USD | -2.34% | -13.76% | -47.75% | -58.23% | 107.54 M USD | ||
| 3816 | LENZ LENZ Therapeutics, Inc. - Common Stock | 3.37 USD | -5.60% | -7.16% | -20.33% | -89.63% | 105.89 M USD | ||
| 3818 | DH Definitive Healthcare Corp. - Class A Common Stock | 1.00 USD | 0.00% | +1.01% | +3.09% | -65.52% | 106.74 M USD | ||
| 3819 | CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 7.19 USD | -4.64% | +0.70% | +1.27% | +108.41% | 107.73 M USD | ||
| 3823 | INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.02 USD | -1.92% | -6.42% | -11.30% | -58.20% | 105.47 M USD | ||
| 3825 | ADAG Adagene Inc - ADS, each representing 1.25 | 2.21 USD | -7.92% | -17.23% | -33.23% | +20.11% | 104.72 M USD | ||
| 3827 | STXS Stereotaxis, Inc. Common Stock | 1.05 USD | -0.94% | -5.41% | -22.79% | -49.52% | 105.21 M USD | ||
| 3833 | VANI Vivani Medical, Inc. - Common Stock | 1.12 USD | -2.61% | -9.68% | -8.20% | -25.33% | 101.03 M USD | ||
| 3835 | COYA Coya Therapeutics, Inc. - Common Stock | 4.30 USD | -0.92% | -14.00% | -5.29% | -31.53% | 100.87 M USD | ||
| 3836 | IMDX Insight Molecular Diagnostics Inc. - Common Stock | 2.97 USD | -2.94% | -10.00% | -19.07% | -35.43% | 97.19 M USD | ||
| 3837 | PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.96 USD | +0.51% | -2.00% | -4.85% | -95.64% | 97.70 M USD | ||
| 3840 | CBUS Cibus, Inc. - Class A Common Stock | 1.31 USD | +1.55% | -14.94% | -16.03% | -19.14% | 100.12 M USD | ||
| 3843 | LUCD Lucid Diagnostics Inc. - Common Stock | 0.49 USD | -5.77% | -23.44% | -40.24% | -59.50% | 99.59 M USD |
ニュース ヘルスケア株
ウィリアム・ブレア、IDEAYAバイオサイエンシズのカバレッジを開始し、アウトパフォーム評価を付与
レベレーション・バイオサイエンシズ、10月20日付で1対7の株式併合を発表
Gate、NeoSoul(DNA)の契約・レバレッジ・スワップ・コピートレードなど複数サービスを上場
Curis、1,666万6,000株の普通株式とワラントを1株当たり0.51ドルで約850万ドル規模で募集開始
タンゴ・セラピューティクス、ESMO Congress 2026において、MTAPdel/RASmut転移性膵管腺癌(PDAC)および非小細胞肺癌(NSCLC)患者を対象とした、ボピメトスタットとダラキソンラシブまたはゾルドンラシブの併用による第1/2相試験の最新データを発表へ
Fractyl HealthのREMAIN-1試験、6カ月の共同主要評価項目を高い統計学的有意性で達成;GLP-1誘導による減量の80%を維持し、シャム群の67%を上回ることを示す
ゴールドマン・サックスがエランコ・アニマルヘルスのカバレッジを開始、投資判断「買い」、目標株価32ドルを発表
上昇銘柄ヘルスケア株
NXGLW NexGel, Inc - Warrant | 0.0085 | +30.77% |
PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
MRKR Marker Therapeutics, Inc. - Common Stock | 1.08 | +17.39% |
REVBW Revelation Biosciences, Inc. - Warrant | 0.0075 | +17.19% |
EXOZ eXoZymes Inc. - Common Stock | 4.61 | +15.25% |
TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.49 | +14.22% |
NMRA Neumora Therapeutics, Inc. - Common Stock | 0.49 | +13.95% |
CTSO Cytosorbents Corporation - Common Stock | 3.37 | +10.13% |
下落銘柄ヘルスケア株
MDXH MDxHealth SA - American Depositary Shares | 0.22 | -63.33% |
GUTS Fractyl Health, Inc. - Common Stock | 1.98 | -52.40% |
REVB Revelation Biosciences, Inc. - Common Stock | 0.48 | -36.84% |
CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
CRIS Curis, Inc. - Common Stock | 0.40 | -21.57% |
ESLA Estrella Immunopharma, Inc. - Common Stock | 0.43 | -20.37% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.1338 | -20.36% |
JAGX Jaguar Health, Inc. - Common Stock | 3.68 | -19.83% |